GlassScriptPhysician profile
Bradley W Bruner
NPI 1548208176
$874.80
in general payments reported to CMS, 2019-2025
14 companies · $52.98 in 2025
The $52.98 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $59.91 · 2021: $311 · 2022: $112 · 2023: $43.95 · 2025: $52.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $96.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $96.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $326.77 | 2019-2021 | |
| Horizon Therapeutics Plc | $232.55 | 2019-2022 | |
| Pacira Therapeutics, INC. | $60.65 | 2019-2021 | |
| Organogenesis INC. | $33.17 | 2021 | |
| Pfizer INC. | $28.32 | 2021 | |
| Smith+Nephew, INC. | $27.27 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $25.80 | 2022 | |
| Depuy Synthes Sales INC. | $25.36 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $24.06 | 2025 | |
| Avanos Medical | $21.98 | 2023 | Pnb and Accessories |
| Pacira Pharmaceuticals Incorporated | $21.97 | 2023 | Exparel, Zilretta, Iovera |
| Heron Therapeutics, INC. | $19.41 | 2022 | |
| Inspire Medical Systems, INC. | $15.38 | 2025 | Inspire |
| Innovation Technologies INC | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Bruner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.